- Home
- NBRG vs INMB Comparison
NBRG vs INMB Comparison
Compare NBRG & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.26
Company Overview
Basic Information| Metric | NBRG | INMB |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 64.7M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NBRG | INMB |
|---|---|---|
| Price | $10.09 | $2.26 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 4.3K | ★ 303.1K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $9.59 | $1.09 |
| 52 Week High | $10.09 | $2.60 |
Technical Indicators
Market Signals| Indicator | NBRG | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 71.53 | 54.80 |
| Support Level | $9.96 | $2.21 |
| Resistance Level | N/A | $2.50 |
| Average True Range (ATR) | 0.01 | 0.14 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 100.00 | 35.71 |
Price Performance
Historical Comparison NBRG
INMB
About NBRG Newbridge Acquisition Limited Class A Ordinary Share
Newbridge Acquisition Ltd is a blank check company.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.